The LAT-ATTC (London Advanced Therapies Advanced Therapy Treatment Centre) is a London-born consortium focused on engaging in national forums to support the implementation of clinical trial acceleration initiatives with the goal of enhancing and strengthening the country’s competitive advantage in ATMP delivery.

The MW-ATTC aims to address the challenge that there is a ‘Lack of ATMP specific PPIE activity, leading to a lack of understanding of ATMPs and lower participation in trials.’

Northern Alliance Advanced Therapies Treatment Centre (NA-ATTC) is a consortium covering North-East England and Scotland focused on developing and rolling out an ATMP training programme across the UK for health professionals working in the field of ATMP clinical trials.

CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies, with a vision for a thriving industry delivering life-changing advanced therapies to the world. CGT Catapult is providing coordination of the ATTC network.